Keith Jason August MD

Pediatric Hematology & Oncology•Kansas City, MO

Professor of Pediatrics, University of Missouri-Kansas City School of Medicine

2401 Gillham Rd.Kansas City, MO 64108

Dr. August is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. August's full profile Already have an account?

Education & Training

Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2005 - 2008
University of Louisville School of MedicineResidency, Pediatrics, 2002 - 2005
University of Oklahoma College of MedicineClass of 2002

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

KS State Medical License 2011 - 2027
MO State Medical License 2009 - 2027
GA State Medical License 2005 - 2011
OK State Medical License 2009 - 2010
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults
TERMINATED
PHASE2
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma Start of enrollment: 2016 Mar 01
COMPLETED
PHASE1, PHASE2
A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer Start of enrollment: 2016 Aug 29
COMPLETED
PHASE1

Publications & Presentations

PubMed

Frailty in Children and Adolescents With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Receiving Maintenance Chemotherapy-A Pilot Study.
Thomas R Cochran, Joy Fulbright, Samantha Butrous, Brian Lee, Keith August
Journal of Pediatric Hematology/oncology. 2026-08-01
Severe Thiopurine-Induced Myelosuppression in a Pediatric Acute Lymphoblastic Leukemia Patient With the NUDT15 *1/*6 Genotype: A Brief Report.
Jillian Fry, Erin C Boone, Wendy Y Wang, Shobana John, Lisa A Lansdon
Clinical and Translational Science. 2026-06-01
Proof-of-concept study for the detection of somatic structural variant driver alterations using HiFi long-read sequencing in a pediatric leukemia cohort.
Lisa A Lansdon, Byunggil Yoo, Ayse Keskus, Irina Pushel, Chengpeng Bi
NPJ Genomic Medicine. 2026-04-09